| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $12.9M | +824.4% |
| R&D Expense | $75.8M | +8.9% |
| SG&A Expense | $64.1M | +35.4% |
| Operating Income | -$128.2M | -10.9% |
| Interest Expense | $1.0M | — |
| Pre-tax Income | -$127.0M | -10.0% |
| Income Tax | -$13.4M | -1239.2% |
| Net Income | -$113.6M | +0.8% |
| EPS (Basic) | -$1.52 | +16.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $44.0M | -43.7% |
| Short-term Investments | $121.0M | +614.9% |
| Accounts Receivable | $1.4M | — |
| Inventory | $1.2M | — |
| Current Assets | $174.6M | +72.8% |
| Total Assets | $236.9M | +74.6% |
| Current Liabilities | $90.4M | +296.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$75.4M | +20.9% |
| Capital Expenditures | $795K | -17.3% |
| Investing Cash Flow | -$88.1M | -183.4% |
| Financing Cash Flow | $129.4M | +26.4% |
| Free Cash Flow | -$76.2M | +20.9% |
| Long-term Debt |
| $26.6M |
| — |
| Total Liabilities | $115.0M | +362.1% |
| Stockholders' Equity | $121.8M | +10.0% |